A 38-year-old woman with type 1 diabetes for 20 years presents with diabetic ketoacidosis. She is treated and recovers. Six months later, she develops progressive fatigue, nausea, and hyperpigmentation. Laboratory studies show morning cortisol 3 μg/dL, ACTH 180 pg/mL, TSH 8.2 mIU/L, free T4 0.6 ng/dL, and positive anti-thyroid peroxidase antibodies. She also has positive 21-hydroxylase antibodies. Her 12-year-old daughter was recently diagnosed with type 1 diabetes. Evaluate the pathologic process and most critical monitoring recommendation for the daughter.
Q2
A 29-year-old man presents with severe headaches and episodic palpitations, sweating, and anxiety. During an episode, blood pressure is 240/130 mmHg. Between episodes, blood pressure is 135/85 mmHg. 24-hour urine shows metanephrines 4.2 mg (normal: <1.0). MRI reveals a 4 cm right adrenal mass. His brother died suddenly at age 25 from an intracranial hemorrhage, and his father had thyroid cancer. Genetic testing reveals a RET proto-oncogene mutation. Evaluate the pathologic syndrome and preoperative management priority.
Q3
A 62-year-old man presents with confusion and severe muscle weakness. He recently started treatment for small cell lung cancer. Laboratory studies show sodium 118 mEq/L, serum osmolality 245 mOsm/kg, urine osmolality 520 mOsm/kg, and urine sodium 85 mEq/L. He is clinically euvolemic with blood pressure 125/80 mmHg. Serum cortisol and TSH are normal. Evaluate the pathophysiologic mechanism and most appropriate initial management given the clinical context.
Q4
A 48-year-old woman undergoes total thyroidectomy for a 2 cm thyroid nodule. Histopathology shows infiltrative tumor cells with nuclear grooves, intranuclear pseudoinclusions, and psammoma bodies. Immunohistochemistry is positive for thyroglobulin and TTF-1. Ten years later, she presents with a lung nodule. Biopsy of the lung lesion shows similar histology with positive thyroglobulin staining. Analyze the pathologic features that predicted this clinical course.
Q5
A 35-year-old woman presents with fatigue, hyperpigmentation of skin creases and buccal mucosa, and salt craving. Blood pressure is 85/55 mmHg. Laboratory studies show sodium 128 mEq/L, potassium 5.8 mEq/L, and glucose 65 mg/dL. Morning cortisol is 2 μg/dL and ACTH is 285 pg/mL (normal: 10-60). After cosyntropin stimulation, cortisol remains at 3 μg/dL. CT scan shows bilateral small adrenal glands with calcifications. Analyze the pathologic mechanism explaining her hyperpigmentation.
Q6
A 42-year-old man with MEN 1 syndrome presents with severe epigastric pain and diarrhea. He has a history of recurrent peptic ulcers despite PPI therapy and recently passed a kidney stone. Laboratory studies show calcium 12.5 mg/dL, PTH 145 pg/mL (normal: 10-65), gastrin 1,200 pg/mL (normal: <100). Upper endoscopy reveals multiple duodenal and gastric ulcers. Analyze the pathologic sequence that best explains his clinical presentation.
Q7
A 55-year-old woman presents with progressive weakness, weight gain, and easy bruising. She has central obesity, moon facies, and purple striae on her abdomen. Blood pressure is 165/95 mmHg. Laboratory studies show glucose 185 mg/dL, morning cortisol 42 μg/dL (normal: 5-25), and ACTH <5 pg/mL (normal: 10-60). A 1-mg overnight dexamethasone suppression test shows cortisol of 38 μg/dL. CT scan shows a 3.5 cm left adrenal mass and atrophy of the right adrenal gland. Apply pathologic principles to explain the contralateral adrenal appearance.
Q8
A 28-year-old man presents with polyuria (6 liters/day), polydipsia, and nocturia for 2 months. He has no significant medical history. Serum sodium is 148 mEq/L, serum osmolality 305 mOsm/kg, and urine osmolality 180 mOsm/kg. After 8-hour water deprivation, urine osmolality increases to 250 mOsm/kg. Following administration of desmopressin, urine osmolality increases to 650 mOsm/kg. Apply this data to determine the diagnosis.
Q9
A 32-year-old woman with a history of postpartum hemorrhage 18 months ago presents with fatigue, cold intolerance, and inability to lactate after delivery. She reports having no menstrual periods since delivery and has gained 15 pounds. Laboratory studies show low TSH, low free T4, low cortisol, and low estradiol. Apply your knowledge to determine the underlying pathologic process.
Q10
A 45-year-old woman presents with a 3-month history of heat intolerance, weight loss, and palpitations. Physical examination reveals exophthalmos, diffuse thyroid enlargement, and a fine tremor. Laboratory studies show TSH <0.01 mIU/L (normal: 0.4-4.0), free T4 6.8 ng/dL (normal: 0.8-1.8), and positive TSH receptor antibodies. A thyroid ultrasound shows diffuse enlargement with increased vascularity. Apply the pathophysiologic mechanism to explain her ocular findings.
Endocrine pathology US Medical PG Practice Questions and MCQs
Question 1: A 38-year-old woman with type 1 diabetes for 20 years presents with diabetic ketoacidosis. She is treated and recovers. Six months later, she develops progressive fatigue, nausea, and hyperpigmentation. Laboratory studies show morning cortisol 3 μg/dL, ACTH 180 pg/mL, TSH 8.2 mIU/L, free T4 0.6 ng/dL, and positive anti-thyroid peroxidase antibodies. She also has positive 21-hydroxylase antibodies. Her 12-year-old daughter was recently diagnosed with type 1 diabetes. Evaluate the pathologic process and most critical monitoring recommendation for the daughter.
A. Multiple endocrine neoplasia syndrome; screen for pheochromocytoma and medullary thyroid cancer
B. Autoimmune polyglandular syndrome type 2; screen daughter for adrenal antibodies and thyroid function annually (Correct Answer)
C. Schmidt syndrome with isolated sporatic occurrence; routine diabetes management only for daughter
D. Autoimmune polyglandular syndrome type 1; screen for mucocutaneous candidiasis and hypoparathyroidism
E. Secondary endocrine failure from diabetes complications; optimize glycemic control in daughter
Explanation: ***Autoimmune polyglandular syndrome type 2; screen daughter for adrenal antibodies and thyroid function annually***
- The patient presents with **Schmidt syndrome (APS type 2)**, defined by the triad of **Addison's disease** (low cortisol, high ACTH, 21-hydroxylase antibodies), **type 1 diabetes**, and **autoimmune thyroid disease** (Hashimoto's).
- Because APS-2 is **polygenic** and associated with **HLA-DR3/DR4**, first-degree relatives with one component (like the daughter) require screening for other silent autoimmune conditions to prevent **adrenal crisis**.
*Multiple endocrine neoplasia syndrome; screen for pheochromocytoma and medullary thyroid cancer*
- **MEN syndromes** are characterized by **neoplastic** growths (like medullary thyroid cancer or parathyroid adenomas) rather than the **autoimmune destruction** of glands seen here.
- The absence of hypertension or neck masses and the presence of **autoantibodies** directly contradict a diagnosis of MEN.
*Schmidt syndrome with isolated sporatic occurrence; routine diabetes management only for daughter*
- While the patient does have **Schmidt syndrome**, it is incorrect to label it as purely sporadic because it has a strong **familial clustering** component.
- Managing only diabetes in the daughter is insufficient and dangerous, as it ignores her increased risk for life-threatening **primary adrenal insufficiency**.
*Autoimmune polyglandular syndrome type 1; screen for mucocutaneous candidiasis and hypoparathyroidism*
- **APS-1** typically presents in childhood with the triad of **chronic mucocutaneous candidiasis**, **hypoparathyroidism**, and adrenal failure, which does not match this adult patient’s profile.
- APS-1 is caused by a single gene mutation in **AIRE**, whereas this patient's presentation and family history are classic for the polygenic **APS-2**.
*Secondary endocrine failure from diabetes complications; optimize glycemic control in daughter*
- Diabetic complications lead to **microvascular** or **macrovascular** damage, not the **primary gland failure** (indicated by high ACTH and TSH) seen in this patient.
- **Hyperpigmentation** and the presence of **organ-specific antibodies** (21-hydroxylase) confirm an **autoimmune primary failure**, not a secondary metabolic complication.
Question 2: A 29-year-old man presents with severe headaches and episodic palpitations, sweating, and anxiety. During an episode, blood pressure is 240/130 mmHg. Between episodes, blood pressure is 135/85 mmHg. 24-hour urine shows metanephrines 4.2 mg (normal: <1.0). MRI reveals a 4 cm right adrenal mass. His brother died suddenly at age 25 from an intracranial hemorrhage, and his father had thyroid cancer. Genetic testing reveals a RET proto-oncogene mutation. Evaluate the pathologic syndrome and preoperative management priority.
A. MEN 2A with pheochromocytoma; alpha-blockade then beta-blockade before thyroid evaluation and surgery (Correct Answer)
B. MEN 2A with pheochromocytoma; screen for medullary thyroid cancer before any surgery
C. Isolated familial pheochromocytoma; genetic counseling after tumor resection
D. MEN 2B with pheochromocytoma; proceed directly to adrenalectomy for blood pressure control
E. Von Hippel-Lindau syndrome; screen for CNS hemangioblastomas before surgery
Explanation: ***MEN 2A with pheochromocytoma; alpha-blockade then beta-blockade before thyroid evaluation and surgery***
- The presence of a **RET proto-oncogene** mutation, family history of thyroid cancer, and a **pheochromocytoma** (elevated metanephrines) confirms **Multiple Endocrine Neoplasia type 2A (MEN 2A)**.
- Medical management must prioritize **alpha-blockade** followed by **beta-blockade** to prevent a lethal **hypertensive crisis** during any subsequent surgical intervention.
*MEN 2A with pheochromocytoma; screen for medullary thyroid cancer before any surgery*
- While screening for **medullary thyroid cancer (MTC)** is necessary in MEN 2A, the immediate clinical priority is stabilizing the patient's blood pressure.
- Performing a thyroid evaluation or surgery before controlling the **catecholamine surge** from the pheochromocytoma carries a high risk of intraoperative mortality.
*Isolated familial pheochromocytoma; genetic counseling after tumor resection*
- This diagnosis is incorrect because the **RET mutation** and family history of thyroid cancer specifically define a **MEN 2 syndrome**, not an isolated condition.
- Genetic counseling and screening of family members are critical, but managing the active **endocrine emergency** takes precedence over post-operative counseling.
*MEN 2B with pheochromocytoma; proceed directly to adrenalectomy for blood pressure control*
- **MEN 2B** is typically characterized by **mucosal neuromas** and a marfanoid habitus, which are not described in this patient.
- Proceeding directly to surgery without **preoperative alpha-blockade** is contraindicated as it can trigger a massive release of catecholamines during tumor manipulation.
*Von Hippel-Lindau syndrome; screen for CNS hemangioblastomas before surgery*
- **Von Hippel-Lindau (VHL)** is associated with the VHL gene mutation on chromosome 3, whereas this patient has a confirmed **RET mutation**.
- While VHL patients do develop pheochromocytomas, the family history of thyroid cancer strongly points toward **MEN 2** rather than VHL.
Question 3: A 62-year-old man presents with confusion and severe muscle weakness. He recently started treatment for small cell lung cancer. Laboratory studies show sodium 118 mEq/L, serum osmolality 245 mOsm/kg, urine osmolality 520 mOsm/kg, and urine sodium 85 mEq/L. He is clinically euvolemic with blood pressure 125/80 mmHg. Serum cortisol and TSH are normal. Evaluate the pathophysiologic mechanism and most appropriate initial management given the clinical context.
A. Primary polydipsia with sodium restriction; liberalize sodium intake
B. Cerebral salt wasting from brain metastases; treat with hypertonic saline
C. Adrenal insufficiency from lung cancer; administer hydrocortisone
D. SIADH from ectopic ADH production; restrict fluids and use vaptans (Correct Answer)
E. Reset osmostat from chemotherapy; observation only
Explanation: ***SIADH from ectopic ADH production; restrict fluids and use vaptans***
- The patient presents with **hypotonic hyponatremia**, **euvolemia**, and inappropriately **concentrated urine** (>100 mOsm/kg), which are classic hallmarks of **SIADH**.
- **Small cell lung cancer** is a well-known cause of **ectopic ADH production**, leading to water retention and secondary **natriuresis** (elevated urine sodium >40 mEq/L).
*Primary polydipsia with sodium restriction; liberalize sodium intake*
- In primary polydipsia, the **urine osmolality** would be very low (typically <100 mOsm/kg) as the body attempts to excrete excess water.
- This patient's urine osmolality is **520 mOsm/kg**, indicating an inability to dilute urine due to excessive **ADH activity**.
*Cerebral salt wasting from brain metastases; treat with hypertonic saline*
- **Cerebral salt wasting (CSW)** presents with **hypovolemia**, whereas this patient is clinically **euvolemic**.
- CSW typically occurs following **neurosurgery or head trauma**, not as a primary presentation of lung cancer without neurological intervention.
*Adrenal insufficiency from lung cancer; administer hydrocortisone*
- While lung cancer can metastasize to the adrenals, this patient has a **normal serum cortisol**, which effectively rules out **adrenal insufficiency**.
- Adrenal insufficiency would more likely present with **hyperkalemia** and signs of **volume depletion** (hypovolemia).
*Reset osmostat from chemotherapy; observation only*
- **Reset osmostat** is a variant of SIADH where the body regulates sodium at a lower set point, but the **urine osmolality** usually fluctuates with water intake.
- This patient's profound **hyponatremia (118 mEq/L)** and severe symptoms (confusion, weakness) necessitate active management rather than mere **observation**.
Question 4: A 48-year-old woman undergoes total thyroidectomy for a 2 cm thyroid nodule. Histopathology shows infiltrative tumor cells with nuclear grooves, intranuclear pseudoinclusions, and psammoma bodies. Immunohistochemistry is positive for thyroglobulin and TTF-1. Ten years later, she presents with a lung nodule. Biopsy of the lung lesion shows similar histology with positive thyroglobulin staining. Analyze the pathologic features that predicted this clinical course.
A. Papillary architecture allowing lymphatic spread followed by distant metastasis
B. Vascular invasion in the primary tumor predicting hematogenous spread
C. Molecular profile of BRAF mutation conferring metastatic phenotype
D. Psammoma bodies indicating aggressive subtype with high metastatic potential
E. The characteristic nuclear features indicating well-differentiated cancer with prolonged natural history (Correct Answer)
Explanation: ***The characteristic nuclear features indicating well-differentiated cancer with prolonged natural history***
- The presence of **nuclear grooves** and **pseudoinclusions** confirms **Papillary Thyroid Carcinoma (PTC)**, which is a well-differentiated malignancy known for its **indolent clinical course**.
- A 10-year latency before the discovery of a **lung metastasis** is characteristic of PTC's slow progression and high overall survival rate despite distant spread.
*Papillary architecture allowing lymphatic spread followed by distant metastasis*
- While PTC frequently spreads to **regional lymph nodes**, lymphatic spread is not the primary predictor for distant hematogenous metastasis to the lungs.
- The **papillary architecture** itself is a morphological pattern and doesn't explain the long-term temporal progression seen in this patient.
*Vascular invasion in the primary tumor predicting hematogenous spread*
- **Vascular invasion** is a hallmark feature of **Follicular Thyroid Carcinoma**, whereas PTC typically spreads through the lymphatic system first.
- While hematogenous spread must occur for lung nodules to form, it is not the defining histologic feature of PTC described in the histopathology report.
*Molecular profile of BRAF mutation conferring metastatic phenotype*
- While the **BRAF V600E mutation** is common in PTC, it is primarily associated with **lymph node metastasis** and extrathyroidal extension rather than specifically predicting late lung nodules.
- The clinical course in this case is better explained by the general nature of **well-differentiated thyroid cancer** rather than a specific metastatic molecular phenotype.
*Psammoma bodies indicating aggressive subtype with high metastatic potential*
- **Psammoma bodies** (laminated calcifications) are a classic diagnostic feature of PTC but do not indicate an aggressive subtype or higher metastatic potential.
- They represent **infarcted papillae** and are actually markers of the tumor's specific growth pattern rather than indicators of poor prognosis.
Question 5: A 35-year-old woman presents with fatigue, hyperpigmentation of skin creases and buccal mucosa, and salt craving. Blood pressure is 85/55 mmHg. Laboratory studies show sodium 128 mEq/L, potassium 5.8 mEq/L, and glucose 65 mg/dL. Morning cortisol is 2 μg/dL and ACTH is 285 pg/mL (normal: 10-60). After cosyntropin stimulation, cortisol remains at 3 μg/dL. CT scan shows bilateral small adrenal glands with calcifications. Analyze the pathologic mechanism explaining her hyperpigmentation.
A. Autoimmune destruction of melanocytes concurrent with adrenal disease
B. Direct melanocyte stimulation by elevated cortisol metabolites
C. Hemochromatosis causing both adrenal failure and skin changes
D. Cross-reactivity of elevated ACTH with melanocortin receptors (Correct Answer)
E. Hepatic dysfunction from hypocortisolism affecting bilirubin metabolism
Explanation: ***Cross-reactivity of elevated ACTH with melanocortin receptors***
- In **primary adrenal insufficiency** (Addison's disease), the loss of cortisol negative feedback leads to a massive increase in **pro-opiomelanocortin (POMC)** production, which is the precursor for both **ACTH** and **MSH**.
- High levels of **ACTH** can directly stimulate **melanocortin-1 receptors (MC1R)** on melanocytes, leading to the characteristic **hyperpigmentation** of skin creases and mucous membranes.
*Autoimmune destruction of melanocytes concurrent with adrenal disease*
- Autoimmune conditions like **vitiligo** involve the destruction of melanocytes, which would result in **depigmentation** (white patches) rather than hyperpigmentation.
- While autoimmune adrenalitis can coexist with vitiligo in **Polyglandular Autoimmune Syndrome**, it does not explain the diffuse hyperpigmentation seen here.
*Direct melanocyte stimulation by elevated cortisol metabolites*
- This patient has **hypocortisolism** (morning cortisol 2 μg/dL); therefore, there are no elevated cortisol metabolites to stimulate melanocytes.
- It is the **deficiency of cortisol** that triggers the pituitary to overproduce hormones that cause skin darkening.
*Hemochromatosis causing both adrenal failure and skin changes*
- **Hemochromatosis** would typically present with high iron, potential liver disease, and a "bronze" skin tone, but it usually causes **secondary adrenal insufficiency** (low ACTH) if the pituitary is involved.
- The **elevated ACTH** and **adrenal calcifications** point toward primary pathology like **tuberculosis** or autoimmune disease rather than iron overload.
*Hepatic dysfunction from hypocortisolism affecting bilirubin metabolism*
- **Hypocortisolism** does not typically cause jaundice or significant hepatic dysfunction that would present as hyperpigmentation.
- **Bilirubin metabolism** issues result in **jaundice** (yellowing of skin/sclera), which is clinically distinct from the melanin-driven darkening seen in **Addison's disease**.
Question 6: A 42-year-old man with MEN 1 syndrome presents with severe epigastric pain and diarrhea. He has a history of recurrent peptic ulcers despite PPI therapy and recently passed a kidney stone. Laboratory studies show calcium 12.5 mg/dL, PTH 145 pg/mL (normal: 10-65), gastrin 1,200 pg/mL (normal: <100). Upper endoscopy reveals multiple duodenal and gastric ulcers. Analyze the pathologic sequence that best explains his clinical presentation.
A. Combined parathyroid adenoma and gastrinoma as part of MEN 1 syndrome (Correct Answer)
B. Primary hyperparathyroidism causing hypercalcemia and subsequent gastrin elevation
C. Parathyroid hyperplasia with secondary hypergastrinemia from calcium effects
D. Gastrinoma causing peptic ulcers with unrelated hyperparathyroidism
E. Multiple endocrine neoplasia causing sequential organ involvement
Explanation: ***Combined parathyroid adenoma and gastrinoma as part of MEN 1 syndrome***
- The patient exhibits the classic triad of **Multiple Endocrine Neoplasia Type 1 (MEN1)**, specifically **primary hyperparathyroidism** (hypercalcemia, elevated PTH, kidney stones) and a **gastrinoma** (Zollinger-Ellison syndrome).
- These tumors occur simultaneously due to germline mutations in the **MEN1 tumor suppressor gene**, rather than one tumor causing the other to develop.
*Primary hyperparathyroidism causing hypercalcemia and subsequent gastrin elevation*
- While **hypercalcemia** can physiologically stimulate mild gastrin release, it cannot account for a gastrin level of **1,200 pg/mL** or refractory duodenal ulcers.
- This explanation ignores the primary neoplastic nature of the **pancreatic islet cell tumor** (gastrinoma) inherent to the MEN 1 syndrome.
*Parathyroid hyperplasia with secondary hypergastrinemia from calcium effects*
- **Parathyroid hyperplasia** is the most common cause of hyperparathyroidism in MEN 1, but
Question 7: A 55-year-old woman presents with progressive weakness, weight gain, and easy bruising. She has central obesity, moon facies, and purple striae on her abdomen. Blood pressure is 165/95 mmHg. Laboratory studies show glucose 185 mg/dL, morning cortisol 42 μg/dL (normal: 5-25), and ACTH <5 pg/mL (normal: 10-60). A 1-mg overnight dexamethasone suppression test shows cortisol of 38 μg/dL. CT scan shows a 3.5 cm left adrenal mass and atrophy of the right adrenal gland. Apply pathologic principles to explain the contralateral adrenal appearance.
A. Congenital hypoplasia unrelated to current condition
B. Metastatic disease causing bilateral involvement
C. Ischemic atrophy from mass effect on blood supply
D. Suppression of ACTH leading to atrophy of normal tissue (Correct Answer)
E. Autoimmune destruction secondary to adrenal adenoma
Explanation: ***Suppression of ACTH leading to atrophy of normal tissue***
- The patient has an **ACTH-independent** cortisol-secreting adrenal adenoma, which produces excessive cortisol that exerts **negative feedback** on the pituitary gland.
- This suppression results in low serum **ACTH levels**, leading to the **disuse atrophy** of the contralateral (normal) adrenal cortex as it lacks the trophic stimulation required to maintain its size.
*Congenital hypoplasia unrelated to current condition*
- Congenital adrenal hypoplasia is a rare developmental disorder and would typically present in **infancy** with adrenal insufficiency.
- It does not explain the presence of a 3.5 cm functional **adrenal mass** or the classic signs of **Cushing syndrome** seen here.
*Metastatic disease causing bilateral involvement*
- Metastatic disease to the adrenals usually results in **bilateral enlargement** or destruction, not unilateral atrophy.
- Metabolism-driven Cushing syndrome is rarely caused by metastases; the low **ACTH** and clinical picture point specifically to a primary functional tumor.
*Ischemic atrophy from mass effect on blood supply*
- A 3.5 cm mass on the left side cannot exert physical **mass effect** or compromise the **blood supply** of the contralateral right adrenal gland.
- Atrophy is a biochemical/hormonal response to the loss of **trophic hormone (ACTH)** signaling, not a mechanical or vascular issue.
*Autoimmune destruction secondary to adrenal adenoma*
- Autoimmune adrenalitis (e.g., **Addison's disease**) typically leads to bilateral adrenal destruction and **elevated ACTH** due to lack of cortisol feedback.
- There is no known mechanism where a functional **adenoma** triggers an autoimmune response specifically targeting the healthy contralateral adrenal tissue.
Question 8: A 28-year-old man presents with polyuria (6 liters/day), polydipsia, and nocturia for 2 months. He has no significant medical history. Serum sodium is 148 mEq/L, serum osmolality 305 mOsm/kg, and urine osmolality 180 mOsm/kg. After 8-hour water deprivation, urine osmolality increases to 250 mOsm/kg. Following administration of desmopressin, urine osmolality increases to 650 mOsm/kg. Apply this data to determine the diagnosis.
A. Osmotic diuresis from diabetes mellitus
B. Central diabetes insipidus (Correct Answer)
C. Diabetes insipidus with partial nephrogenic component
D. Nephrogenic diabetes insipidus
E. Primary polydipsia
Explanation: ***Central diabetes insipidus***
- The significant increase in **urine osmolality** (>50% and reaching 650 mOsm/kg) after **desmopressin** administration confirms that the kidneys are responsive to ADH, but the body is not producing it.
- Preliminary findings of **hypernatremia** and high **serum osmolality** with dilute urine indicate a failure of the **hypothalamic-pituitary axis** to release antidiuretic hormone.
*Osmotic diuresis from diabetes mellitus*
- This condition would present with high **urine osmolality** (usually >300 mOsm/kg) due to the presence of **glucose** or other solutes.
- The patient's low initial urine osmolality (180 mOsm/kg) and the dramatic response to ADH are inconsistent with a **solute-driven** diuresis.
*Diabetes insipidus with partial nephrogenic component*
- A partial nephrogenic component would show a blunt or **incomplete response** to exogenous desmopressin, rather than a normalize concentration.
- The patient's urine osmolality reached 650 mOsm/kg, which demonstrates a robust and **intact renal response** to ADH analogs.
*Nephrogenic diabetes insipidus*
- In this condition, the kidneys are resistant to ADH, so there would be **minimal to no change** in urine osmolality after giving desmopressin.
- The patient’s urine osmolality more than doubled following **desmopressin**, effectively ruling out a primary **renal tubule defect**.
*Primary polydipsia*
- Patients with primary polydipsia typically have **hyponatremia** and low serum osmolality due to excessive free water intake.
- During a **water deprivation test**, these patients are generally able to concentrate their urine significantly (often >600 mOsm/kg) without needing exogenous hormones.
Question 9: A 32-year-old woman with a history of postpartum hemorrhage 18 months ago presents with fatigue, cold intolerance, and inability to lactate after delivery. She reports having no menstrual periods since delivery and has gained 15 pounds. Laboratory studies show low TSH, low free T4, low cortisol, and low estradiol. Apply your knowledge to determine the underlying pathologic process.
A. Hypothalamic dysfunction from psychological stress
B. Pituitary infarction from severe postpartum hypotension (Correct Answer)
C. Primary adrenal insufficiency with secondary amenorrhea
D. Autoimmune polyglandular syndrome type 2
E. Primary hypothyroidism with concurrent ovarian failure
Explanation: ***Pituitary infarction from severe postpartum hypotension***
- This patient presents with **Sheehan syndrome**, which is ischemic necrosis of the **anterior pituitary** caused by severe **postpartum hemorrhage** and hypotension.
- The deficiency of multiple hormones (**TSH, ACTH, Prolactin, Gonadotropins**) explains her fatigue, cold intolerance, failure to lactate, and secondary **amenorrhea**.
*Hypothalamic dysfunction from psychological stress*
- Stress-induced hypothalamic dysfunction typically leads to **functional hypothalamic amenorrhea**, but it does not cause **hypothyroidism** or profound **hypocortisolism**.
- It would not explain the inability to lactate or the specific history of severe **obstetric hemorrhage**.
*Primary adrenal insufficiency with secondary amenorrhea*
- Primary adrenal insufficiency would typically present with **elevated ACTH** (leading to hyperpigmentation) rather than the low cortisol and low ACTH/TSH seen here.
- It does not account for the **low TSH** and **failure to lactate**, which point to a central pituitary defect.
*Autoimmune polyglandular syndrome type 2*
- This syndrome usually involves **Primary Adrenal Insufficiency (Addison's)** and autoimmune thyroid disease, which would show **elevated TSH** or ACTH levels.
- It is not associated with **postpartum hemorrhage** and would not cause the panhypopituitarism described.
*Primary hypothyroidism with concurrent ovarian failure*
- Primary hypothyroidism would result in an **elevated TSH** level as the pituitary attempts to compensate for low thyroid hormone.
- Primary ovarian failure would present with **elevated FSH and LH** (hypergonadotropic hypogonadism) rather than the low estradiol and amenorrhea seen in pituitary failure.
Question 10: A 45-year-old woman presents with a 3-month history of heat intolerance, weight loss, and palpitations. Physical examination reveals exophthalmos, diffuse thyroid enlargement, and a fine tremor. Laboratory studies show TSH <0.01 mIU/L (normal: 0.4-4.0), free T4 6.8 ng/dL (normal: 0.8-1.8), and positive TSH receptor antibodies. A thyroid ultrasound shows diffuse enlargement with increased vascularity. Apply the pathophysiologic mechanism to explain her ocular findings.
A. Sympathetic hyperactivity causing lid retraction only
B. Autoimmune inflammation and glycosaminoglycan deposition in retro-orbital tissues (Correct Answer)
C. Hyperthyroid-induced increased intraocular pressure
D. Compression of orbital veins by enlarged thyroid gland
E. Direct infiltration of orbital muscles by thyroid tissue
Explanation: ***Autoimmune inflammation and glycosaminoglycan deposition in retro-orbital tissues***
- In **Graves' ophthalmopathy**, T-cells and **TSH receptor antibodies** activate retro-orbital fibroblasts, leading to the accumulation of **glycosaminoglycans** (e.g., hyaluronic acid).
- This deposition causes osmotic edema, resulting in **proptosis (exophthalmos)** and extraocular muscle enlargement, which are distinct features of this autoimmune condition.
*Sympathetic hyperactivity causing lid retraction only*
- While **sympathetic overactivity** causes the characteristic **lid lag** and retraction seen in any form of hyperthyroidism, it does not explain true **exophthalmos**.
- Exophthalmos is a tissue-expansion process unique to **Graves' disease**, whereas lid retraction is a functional effect of increased adrenergic tone on the **Müller muscle**.
*Hyperthyroid-induced increased intraocular pressure*
- Although **intraocular pressure** can occasionally rise due to muscle compression in severe Graves', it is a secondary consequence rather than the primary cause of exophthalmos.
- The clinical displacement of the eyeball is driven by **retro-orbital tissue volume** expansion, not by fluid dynamics within the globe (glaucoma).
*Compression of orbital veins by enlarged thyroid gland*
- The **thyroid gland** is located in the neck and has no anatomical pathway to compress **orbital veins** at the level of the skull or orbit.
- Venous congestion in the eye is caused by **local pressure** within the bony orbit from swollen muscles and fat, not by the systemic size of the thyroid gland.
*Direct infiltration of orbital muscles by thyroid tissue*
- The extraocular muscles are enlarged due to **inflammation**, edema, and fatty infiltration, not by the migration or growth of **thyroid tissue** itself.
- There is no mechanism for **ectopic thyroid tissue** to develop within the orbit; the pathology is a localized **autoimmune response** to shared antigens like the TSH receptor.
